cobalt has been researched along with imatinib mesylate in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abraham, A; Gastl, G; Gust, R; Kircher, B; Ott, I; Schumacher, P; Shorafa, H | 1 |
1 other study(ies) available for cobalt and imatinib mesylate
Article | Year |
---|---|
Synergistic and additive antiproliferative effects on human leukemia cell lines induced by combining acetylenehexacarbonyldicobalt complexes with the tyrosine kinase inhibitor imatinib.
Topics: Benzamides; Cell Line, Tumor; Cell Proliferation; Cobalt; Drug Screening Assays, Antitumor; Drug Synergism; HL-60 Cells; Humans; Imatinib Mesylate; Inhibitory Concentration 50; Leukemia; Molecular Structure; Organometallic Compounds; Piperazines; Protein Kinase Inhibitors; Pyrimidines | 2006 |